Roche Diabetes Care - Accu Chek

What Roche Diabetes Care - Accu Chek does

Roche Diabetes Care, operating in Brazil through the entity Roche Diabetes Care Brasil Ltda and the Accu-Chek brand, is a division of the Swiss multinational Roche Group (founded 1896). The Brazilian operation sells a comprehensive diabetes management portfolio that includes three blood glucose meter platforms (Active, Guide, Performa) with their corresponding test strips, the SmartGuide continuous glucose monitoring (CGM) sensor, the Accu-Chek Solo insulin pump with FlexLink and TenderLink infusion sets, Accu-Fine insulin pen needles, FastClix and Softclix lancing devices featuring proprietary Clixmotion technology, and the Coaguchek coagulation monitor. All products are ANVISA-registered and meet ISO 15197:2013 accuracy standards. The Accu-Chek brand has 40+ years of presence in Brazil and serves an installed base of 30M+ users globally across more than 100 countries.

The business model is primarily a hardware-plus-consumables razor-and-blade structure: meters, pumps, and CGM sensors are sold as one-time hardware purchases while test strips, lancets, pen needles, infusion sets, and CGM sensors generate recurring consumable revenue. Pricing is in Brazilian Reais with multi-pack tiers (10 to 200 strips), aggressive promotional discounting (40-60% off on key SKUs), installment payments (up to 6x interest-free), and free shipping above R$450. The DiabetesBox subscription program extends the razor-and-blade model into a formal monthly recurring service covering strips, lancets, and insulin pump supplies. Distribution combines an owned direct-to-consumer e-commerce store (loja.accu-chek.com.br, operated by INFRACOMMERCE), pharmacy and healthcare provider channels across all 27 Brazilian states, and social commerce touchpoints (Instagram, Facebook, WhatsApp). The E-Clinic digital health platform adds a software layer for patient-clinician interaction and remote monitoring.

Go-to-market is direct-to-consumer with product-led growth through subscription. Marketing spans organic social (Instagram, Facebook, YouTube), email/newsletter campaigns, seasonal promotions (e.g., Diabetes Week 25), and HCP referrals via E-Clinic. Customer concentration risk is structurally low as the entire addressable market is fragmented individual diabetes patients rather than enterprise accounts; conversely, segment-level exposure to Brazilian diabetes prevalence, reimbursement, and competitive intensity from CGM-first players (Dexcom, Abbott FreeStyle Libre) is the principal risk vector. The combined offering positions Roche as a full-stack diabetes ecosystem rather than a point-solution vendor, though disclosure on AI/ML capabilities, headcount, and unit economics is limited.

Name

Roche Diabetes Care - Accu Chek

Legal name

Roche Diabetes Care Brasil Ltda

Website

https://loja.accu-chek.com.br

Company type

Private

Founded year

1896

Operating status

Operating

Headcount range

11–50 employees

Short description

Roche Diabetes Care operates the Accu-Chek brand in Brazil, selling blood glucose meters, test strips, CGM sensors, insulin pumps, and related consumables to individual diabetes patients through owned e-commerce, pharmacy channels, and a DiabetesBox subscription service across all 27 Brazilian states.

Ownership category

akta.pro rank

Product category

Diabetes Management Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Health and Personal Care Retailers (456), Pharmacies and Drug Retailers (456110)

SIC

Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835), Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG)

akta.pro secondary industries

Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies) (HLAHAHAL), Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE), Patch Pumps & Wearable Insulin Delivery (HLAHAHAC), Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE)

Keywords

• Blood glucose monitoring
• Continuous glucose monitoring
• Insulin delivery systems
• Diabetes management supplies
• Medical diagnostic devices

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

1. Blood Glucose Monitoring (BGM) Products: Sales of blood glucose meters, test strips (Active, Guide, Performa lines), lancets, and lancet devices. These are one-time hardware purchases combined with recurring consumable (strip) revenue.
2. DiabetesBox Subscription Service: Monthly subscription program offering bimonthly delivery of diabetes supplies (strips, lancets, insulin pump consumables) with payment collected via recurring credit card charges. Provides recurring revenue through customer loyalty and planned replenishment.
3. Insulin Pump and Infusion Sets: Sales of Accu-Chek insulin pumps (Solo) and infusion set accessories (FlexLink, TenderLink) along with cartridges, cannulas, and catheters for insulin pump therapy.
4. SmartGuide CGM Sensor Sales: Sales of the Accu-Chek SmartGuide continuous glucose monitoring sensor, offered individually or in multi-sensor combo packs.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Roche Diabetes Care Brasil sells Accu-Chek branded blood glucose meters, test strips, continuous glucose monitoring (CGM) sensors, insulin pumps, infusion sets, lancets, and insulin pen needles directly to people with diabetes in Brazil through an owned e-commerce store. The offering is supplemented by the DiabetesBox recurring subscription service and the E-Clinic digital health platform for patient-clinician interactions.

Product overview

Roche Diabetes Care - Accu Chek offers a comprehensive diabetes management ecosystem under the Accu-Chek brand. The portfolio centers on blood glucose monitoring systems comprising Guide, Performa, and Active meter platforms with their corresponding test strips. Continuous Glucose Monitoring is addressed through the SmartGuide CGM sensor. For insulin delivery, the ecosystem includes the Accu-Chek Solo insulin pump with FlexLink and TenderLink infusion sets, complemented by Accu-Fine pen needles. Supporting products include FastClix and Softclix lancing devices with Clixmotion technology, and the Coaguchek coagulation monitor. The company provides digital services including DiabetesBox (subscription-based supply delivery) and E-Clinic (telemedicine/digital health platform). All products are distributed exclusively through the online store with ANVISA registration and ISO 15197:2013 quality certification.

Differentiator

Problem solved

Functional benefit

Brands

• DiabetesBox: Subscription service for diabetes care products including test strips, offering monthly delivery plans with discounts for subscribers.
• Accu-Chek Active
• Accu-Chek Guide
• Accu-Chek Performa
• Accu-Chek SmartGuide
• Accu-Chek Solo
• Accu-Fine
• Accu-Chek Softclix
• Accu-Chek FastClix

Products and services

• Accu-Chek Guide Blood Glucose Monitor
• Accu-Chek Active Blood Glucose Monitor
• Accu-Chek Guide Test Strips
• Accu-Chek Performa Test Strips
• Accu-Chek Active Test Strips
• Accu-Chek SmartGuide CGM Sensor
• Accu-Chek FastClix Lancets
• Accu-Chek Softclix Lancing Device
• Accu-Fine Insulin Pen Needles
• Accu-Chek Solo Insulin Pump
• Accu-Chek FlexLink Infusion Sets
• Accu-Chek TenderLink Infusion Sets
• Coaguchek Coagulation Monitor
• DiabetesBox Subscription Service
• E-Clinic Digital Health Platform

Quantifiable outcome

• Blood glucose test results in 5 seconds with 0.6 µL blood sample (Accu-Chek Performa)
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core and minor.

• INFRACOMMERCE NEGÓCIOS E SOLUÇÕES EM INTERNET LTDAcoreChannel Partner/ Reseller/ DistributorINFRACOMMERCE operates the official Accu-Chek online store (loja.accu-chek.com.br) as the e-commerce platform and distributor for Roche Diabetes Care Brazil, handling order fulfillment, customer service, and DiabetesBox subscription management.
• SYNAPCOM COMÉRCIO ELETRÔNICO LTDAminorChannel Partner/ Reseller/ DistributorSYNAPCOM is an e-commerce operator for Accu-Chek products, managing subscription fulfillment for some DiabetesBox plans including insulin pump supply plans (FlexLink, TenderLink).

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Abbott Diabetes Care (FreeStyle Libre): Global CGM market leader with FreeStyle Libre sensors directly competing against Accu-Chek SmartGuide; also offers BGM products historically, making it a multi-line competitor.
• Dexcom: Pure-play CGM competitor (G6, G7) competing head-to-head with SmartGuide in the continuous glucose monitoring segment across consumer and prescriber channels.
• Trividia Health (TRUE METRIX): US-based BGM manufacturer (TRUE METRIX, TRUEtrack) competing directly with Accu-Chek in the consumer blood glucose monitoring segment.
• Ypsomed: Swiss manufacturer of insulin pump systems (mylife Loop) and pen needles (mylife Clickfine), competing with both Accu-Chek Solo pumps and Accu-Fine pen needles.
• Tandem Diabetes Care: Maker of the t:slim X2 insulin pump with Control-IQ technology, competing with Accu-Chek Solo in the connected insulin pump market.
• Ascensia Diabetes Care: Direct competitor to Accu-Chek in blood glucose monitoring with the Contour portfolio of meters and test strips, including the Contour Plus and Contour Next lines, sold globally including Latin America.
• Medtronic Diabetes: Competes in both insulin pumps (MiniMed) and CGM (Guardian), directly overlapping with Accu-Chek Solo pump and SmartGuide sensor offerings in the integrated diabetes management space.
• LifeScan (OneTouch): Direct BGM competitor operating the OneTouch brand of meters and Verio test strips, with similar focus on consumer and pharmacy channels for diabetes self-monitoring.
• Insulet Corporation: Maker of the Omnipod tubeless patch insulin pump, competing with Accu-Chek Solo in the wearable insulin delivery category.

Broad incumbents

• Sinocare: Chinese manufacturer of blood glucose meters and test strips with growing global presence, competing with Accu-Chek in BGM with cost-competitive offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/rochediabetescarebr
• Facebookfacebook.com/RocheAccuChekBrasil
• Instagraminstagram.com/accuchek.br
• LinkedInlinkedin.com/company/roche-diabetes-care---accu-chek

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roche Diabetes Care - Accu Chek